Abstract
Get full access to this article
View all access options for this article.
References
1.
Lavernia
F
. What options are available when considering starting insulin: premix or basal? Diabetes Technol Ther , 2011 ; 13 ,Suppl 1 :S-85 –S-92 .
2.NovoLog® Mix 70/30 [package insert] . Princeton, NJ : Novo Nordisk Inc. , 2010 .
3.NovoLog® [package insert] . Princeton, NJ : Novo Nordisk Inc. , 2010 .
4.Levemir® [package insert] . Princeton, NJ : Novo Nordisk Inc. , 2009 .
5.
Klein
O
,
Lynge
J
,
Endahl
L
,
Damholt
B
,
Nosek
L
,
Heise
T
. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes . Diabetes Obes Metab , 2007 ; 9 :290 –299 .
6.
Bilz
S
,
Meienberg
F
,
Flueckiger
M
,
Falconnier
C
,
Keller
U
,
Puder
J
. Comparison of the pharmacodynamic, pharmacokinetic profiles of insulin detemir, insulin glargine in severely obese type 2 diabetic subjects [abstract] The Endocrine Society's 90th Annual Meeting . San Francisco : Endocrine Society , 2008 OR 56-2.